Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 09-2021 | 12-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,750 | 195 | 266 |
| Receivables | 311 | 238 | 145 |
| Inventories | 13 | 7 | 10 |
| Other current assets | 0 | 4,644 | 6,010 |
| TOTAL | $2,146 | $5,097 | $6,470 |
| Non-Current Assets | |||
| PPE Net | 18 | 22 | 27 |
| Intangibles | 6,681 | 7,111 | 8,064 |
| TOTAL | $6,699 | $7,132 | $8,091 |
| Total Assets | $8,845 | $12,229 | $14,562 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 250 | 2,521 |
| Accounts payable and accrued liabilities | 878 | 2,532 | 820 |
| Other current liabilities | 325 | 4,642 | 6,389 |
| TOTAL | $1,233 | $7,424 | $9,751 |
| Non-Current Liabilities | |||
| Long Term Debt | 5,608 | 5,496 | 4,580 |
| Other Non-Current Liabilities | 346 | 2,628 | 923 |
| TOTAL | $5,954 | $8,124 | $5,503 |
| Total Liabilities | $7,187 | $15,548 | $15,254 |
| Shareholders' Equity | |||
| Common Shares | 14,192 | 7,932 | 6,811 |
| Retained earnings | -15,811 | -12,232 | -8,704 |
| Other shareholders' equity | 3,278 | 981 | 1,201 |
| TOTAL | $1,658 | $-3,319 | $-692 |
| Total Liabilities And Equity | $8,845 | $12,229 | $14,562 |